Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy

NCT00445003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

333

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy
Diabetic Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Triamcinolone Acetonide
BEHAVIORAL: Sham injection
PROCEDURE: Focal/grid laser

Sponsor

Jaeb Center for Health Research

Collaborators

[object Object]
[object Object]
[object Object]